West Pharmaceutical Services ROA 2010-2024 | WST

Current and historical return on assets (ROA) values for West Pharmaceutical Services (WST) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
West Pharmaceutical Services ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $0.50B $3.68B 13.67%
2024-06-30 $0.52B $3.49B 14.28%
2024-03-31 $0.57B $3.60B 15.29%
2023-12-31 $0.59B $3.83B 15.84%
2023-09-30 $0.56B $3.76B 15.14%
2023-06-30 $0.52B $3.67B 14.49%
2023-03-31 $0.55B $3.72B 15.78%
2022-12-31 $0.59B $3.62B 17.28%
2022-09-30 $0.63B $3.32B 19.02%
2022-06-30 $0.69B $3.36B 20.95%
2022-03-31 $0.69B $3.30B 21.60%
2021-12-31 $0.66B $3.31B 21.83%
2021-09-30 $0.61B $3.14B 21.08%
2021-06-30 $0.52B $2.93B 18.75%
2021-03-31 $0.42B $2.74B 16.06%
2020-12-31 $0.35B $2.79B 13.78%
2020-09-30 $0.31B $2.58B 13.01%
2020-06-30 $0.29B $2.39B 12.45%
2020-03-31 $0.26B $2.25B 11.71%
2019-12-31 $0.24B $2.34B 11.11%
2019-09-30 $0.23B $2.17B 11.02%
2019-06-30 $0.23B $2.12B 11.28%
2019-03-31 $0.22B $2.04B 11.13%
2018-12-31 $0.21B $1.98B 10.80%
2018-09-30 $0.16B $1.95B 8.21%
2018-06-30 $0.15B $1.87B 8.01%
2018-03-31 $0.13B $1.87B 7.14%
2017-12-31 $0.15B $1.86B 8.20%
2017-09-30 $0.19B $1.93B 10.52%
2017-06-30 $0.18B $1.84B 10.07%
2017-03-31 $0.18B $1.73B 10.62%
2016-12-31 $0.14B $1.72B 8.44%
2016-09-30 $0.14B $1.74B 8.11%
2016-06-30 $0.10B $1.71B 6.06%
2016-03-31 $0.09B $1.67B 5.08%
2015-12-31 $0.10B $1.70B 5.80%
2015-09-30 $0.09B $1.67B 5.70%
2015-06-30 $0.12B $1.66B 7.45%
2015-03-31 $0.13B $1.60B 8.01%
2014-12-31 $0.13B $1.67B 7.52%
2014-09-30 $0.12B $1.67B 7.10%
2014-06-30 $0.12B $1.71B 6.87%
2014-03-31 $0.11B $1.71B 6.49%
2013-12-31 $0.11B $1.67B 6.93%
2013-09-30 $0.11B $1.67B 6.85%
2013-06-30 $0.10B $1.61B 6.24%
2013-03-31 $0.08B $1.58B 5.48%
2012-12-31 $0.08B $1.56B 5.39%
2012-09-30 $0.08B $1.53B 5.41%
2012-06-30 $0.08B $1.46B 5.67%
2012-03-31 $0.09B $1.46B 6.00%
2011-12-31 $0.08B $1.40B 5.45%
2011-09-30 $0.06B $1.40B 4.60%
2011-06-30 $0.06B $1.42B 4.76%
2011-03-31 $0.07B $1.37B 5.09%
2010-12-31 $0.07B $1.29B 5.21%
2010-09-30 $0.08B $1.30B 6.34%
2010-06-30 $0.08B $1.22B 6.31%
2010-03-31 $0.08B $1.25B 6.15%
2009-12-31 $0.07B $1.27B 5.88%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.024B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36